Strategic Asset Management, LLC

Position in BVAXF — BioVaxys Technology Corp.

CIK 1888541 ROCHESTER, MN

Position in BVAXF

as of Sep 30, 2021 · filed Nov 4, 2021 Compact

Position Value

$1,735

New position

Shares Held

500

first reported quarter

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#1

of 1 holders

Holding Since

Sep 2021

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Sep 30, 2022

Strategic Asset Management, LLC holds $279,587 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	ZVRA	Zevra Therapeutics, Inc.	41,743	$260,476
2	VXRT	Vaxart, Inc.	6,000	$13,080
3	ONCY	Oncolytics Biotech Inc	2,500	$3,075
4	MRNA	Moderna, Inc.	25	$2,956
5	CRVO	CervoMed Inc.	40	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2021-09-30	$1,735	5,000	—	Shares	Sole	2021-11-04
No filing history on record for this holder in this stock.